Drug comparisons
Bexagliflozin vs Troglitazone
Bexagliflozin vs Troglitazone: SGLT2i vs withdrawn TZD for type 2 diabetes. Troglitazone caused fatal liver injury and is no longer used.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when patients or providers examine discontinued diabetes drugs versus modern SGLT2 inhibitors like Bexagliflozin.
Bottom line
Bexagliflozin is preferred over Troglitazone because the latter was withdrawn for serious liver risks and is not available.
All medication comparisons